A Meta-analysis of Zinc Salts Lozenges and the Common Cold
Overview
Authors
Affiliations
Background: In the United States, the common cold has been estimated to cost more than $3.5 billion a year. Despite several randomized clinical trials, the effect of treating colds with zinc salts lozenges remains uncertain because of conflicting results.
Objective: To conduct a meta-analysis of published randomized clinical trials on the use of zinc salts lozenges in colds using a random effects model.
Results: Eight clinical trials of treating adults with zinc salts lozenges were identified. After excluding 2 studies that used nasal inoculation of rhinovirus, 6 trials were combined and analyzed. The summary odds ratio for the presence of any cold symptoms at 7 days was 0.50 (95% confidence interval, 0.19-1.29).
Conclusion: Despite numerous randomized trials, the evidence for effectiveness of zinc salts lozenges in reducing the duration of common colds is still lacking.
Zinc for prevention and treatment of the common cold.
Nault D, Machingo T, Shipper A, Antiporta D, Hamel C, Nourouzpour S Cochrane Database Syst Rev. 2024; 5:CD014914.
PMID: 38719213 PMC: 11078591. DOI: 10.1002/14651858.CD014914.pub2.
Abioye A, Bromage S, Fawzi W BMJ Glob Health. 2021; 6(1).
PMID: 33472840 PMC: 7818810. DOI: 10.1136/bmjgh-2020-003176.
Petrus E, Lawson K, Bucci L, Blum K Curr Ther Res Clin Exp. 2020; 59(9):595-607.
PMID: 32287355 PMC: 7118419. DOI: 10.1016/S0011-393X(98)85058-3.
Johnsrud J, Abdallah A, Schichman S, Xiang Z Perm J. 2017; 21:16-077.
PMID: 28241910 PMC: 5283791. DOI: 10.7812/TPP/16-077.
Picon P, Boff Costa M, da Veiga Picon R, Fendt L, Suksteris M, Saccilotto I BMC Infect Dis. 2013; 13:556.
PMID: 24261438 PMC: 4222817. DOI: 10.1186/1471-2334-13-556.